Evidence map›Paper›PMID 22877223›Full record

ReviewBioanalysis2012

Preclinical (1)H-MRS neurochemical profiling in neurological and psychiatric disorders.

Moonnoh R Lee, Aleksandar Denic, David J Hinton, Prasanna K Mishra, Doo-Sup Choi, Istvan Pirko, Moses Rodriguez, Slobodan I Macura

Abstract readReview
In one paragraph

Review in Bioanalysis, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Meta-analysis ofPCN reports : psychiatry and clinical neurosciences · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. The Brain Metabolic Signature in Superagers Using In VivoAJNR. American journal of neuroradiology · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Neuropharmacological and neurobiological relevance of in vivo ¹H-MRS of GABA and glutamate for preclinical drug discovery in mental disorders.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2014
    Article
  16. Article
  17. Article
  18. Alzheimer's disease biomarkers in animal models: closing the translational gap.American journal of neurodegenerative disease · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Moonnoh R LeeDepartment of Biochemistry, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.
Aleksandar Denic
David J Hinton
Prasanna K Mishra
Doo-Sup Choi
Istvan Pirko
Moses Rodriguez
Slobodan I Macura

Funding

T cell Function in Murine Model of Multiple SclerosisR01NS032129 · NINDS · MAYO CLINIC ROCHESTER · PI RODRIGUEZ, MOSES · 1994 to 2010
$2.7M
IMMUNE PROMOTION OF REMYELINATIONR01NS024180 · NINDS · MAYO CLINIC ROCHESTER · PI RODRIGUEZ, MOSES · 1987 to 2008
$2.7M
The Mayo Clinic Center for Individualized Treatment of Alcohol DependenceP20AA017830 · NIAAA · MAYO CLINIC ROCHESTER · PI CHOI, DOO-SUP · 2009 to 2010
$2.5M
Nanopore Biosensor for Kinetics of Reparative Antibodies on Plasma MembranesR01GM092993 · NIGMS · UNIVERSITY OF MINNESOTA · PI OH, SANG-HYUN · 2010 to 2013
$1.6M
CD8+ T cells in formation of T1 black holes in animal model of multiple sclerosisR01NS058698 · NINDS · UNIVERSITY OF CINCINNATI · PI PIRKO, ISTVAN · 2008 to 2011
$1.2M
Genetic Analysis of Spontaneous RemyelinationR01NS048357 · NINDS · MAYO CLINIC ROCHESTER · PI BIEBER, ALLAN JAMES · 2008 to 2011
$1.0M
Clinical Translation of a Neuron Protective Recombinant Human AntibodyR21NS073684 · NINDS · MAYO CLINIC ROCHESTER · PI RODRIGUEZ, MOSES · 2011 to 2012
$434k
NIAAA NIH HHS P20 AA017830NIGMS NIH HHS R01 GM092993NINDS NIH HHS R01 NS024180NINDS NIH HHS R01 NS032129NINDS NIH HHS R01 NS048357NINDS NIH HHS R01 NS058698NINDS NIH HHS R21 NS073684
6 · The paper itself

Abstract

The ongoing development of animal models of neurological and psychiatric disorders in combination with the development of advanced nuclear magnetic resonance (NMR) techniques and instrumentation has led to increased use of in vivo proton NMR spectroscopy ((1)H-MRS) for neurochemical analyses. (1)H-MRS is one of only a few analytical methods that can assay in vivo and longitudinal neurochemical changes associated with neurological and psychiatric diseases, with the added advantage of being a technique that can be utilized in both preclinical and clinical studies. In this review, recent progress in the use of (1)H-MRS to investigate animal models of neurological and psychiatric disorders is summarized with examples from the literature and our own work.

Indexed as

Brain ChemistryAlcoholismAnimalsBiomarkersBrainDisease Models, AnimalHumansMagnetic Resonance ImagingMental DisordersMiceMice, KnockoutMood DisordersMultiple SclerosisNervous System DiseasesNuclear Magnetic Resonance, BiomolecularRatsBiomarkers

Identifiers

PMID22877223
PMCPMC3922617

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.